Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 58 min 59 sec ago

Fiagon Receives FDA Clearance For Brain Surgery

Fri, 04/22/2016 - 16:09
BERLIN, April 22, 2016 -- (Healthcare Sales & Marketing Network) -- Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) 510k clearance for its brain navigation software. The clearance includes the compan...
Devices, Neurosurgery, FDA
Fiagon AG, brain navigation, BiopsyPointer, FlexPointer, ShuntPointer

BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President

Fri, 04/22/2016 - 13:48
VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - BioMmune Technologies Inc. ("BioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune system to fight cancer and autoimmune di...
Biopharmaceuticals, Personnel
BioMmune Technologies

Accuray Hosts Regional AERO Users' Meeting

Fri, 04/22/2016 - 13:40
Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment SUNNYVALE, Calif., April 22, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the Accuray Exchange in Radiation On...
Devices, Oncology
Accuray, CyberKnife, TomoTherapy,

Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development

Thu, 04/21/2016 - 18:02
Dr. Gogas brings over 20 years of industry experience to the company SAN FRANCISCO, April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Symic, a clinical-stage biotherapeutics company developing multiple compounds that target the extracellular ...
Biopharmaceuticals, Personnel
Symic, extracellular matrix

Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity

Thu, 04/21/2016 - 17:56
ALINIQ, A NEW PROFESSIONAL SERVICES AND INFORMATICS PORTFOLIO, IS NOW AVAILABLE WORLDWIDE ABBOTT PARK, Ill., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Abbott (ABT) today announced the global launch of AlinIQ, the first in a series of ...
Diagnostics, Product Launch
Abbott, AlinIQ

eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention

Thu, 04/21/2016 - 15:07
SpringTMS is now available to patients in the United Kingdom for acute treatment of migraine and migraine prevention BALTIMORE, April 21, 2016 -- (Healthcare Sales & Marketing Network) -- eNeura, Inc., a privately held medical technology company, annou...
Devices, Neurology, Regulatory
eNeura, SpringTMS, migraine, Transcranial Magnetic Stimulation

FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer

Thu, 04/21/2016 - 15:03
New Orphan Designation is the Third Awarded to DelMar Pharmaceuticals by FDA Office of Orphan Products Development (OOPD) VANCOUVER, British Columbia and MENLO PARK, Calif., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuti...
Biopharmaceuticals, Oncology, FDA
DelMar Pharmaceuticals, VAL-083, ovarian cancer

Hologic Announces FDA Clearance and Commercial Availability of the Affirm(TM) Prone Biopsy System, the First 2D/3D(TM) Imaging-Guided Dedicated Prone Biopsy System

Thu, 04/21/2016 - 15:01
New System Pairs 360-Degree Breast Access with Exceptional 2D/3D™ Biopsy Imaging MARLBOROUGH, Mass., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (HOLX) today announced the U.S. Food and Drug Administration (FDA) clearance ...
Devices, Oncology, Radiology, FDA, Product Launch
Hologic, prone biopsy

BD Divests Vertebral Augmentation Solutions Business to Stryker

Thu, 04/21/2016 - 14:55
FRANKLIN LAKES, N.J., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which include...
Devices, Orthopaedic, Neurosurgery, Acquisitions
BD, Stryker, AVAmax, AVAflex, AVAtex, AVAprep

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund

Wed, 04/20/2016 - 15:29
Financing to expand the Second Genome Microbiome Discovery Platform and accelerate the clinical development of pipeline programs SOUTH SAN FRANCISCO, Calif., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Second Genome, Inc., a privately-h...
Biopharmaceuticals, Venture Capital, Personnel
Second Genome, microbiome

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem(TM) S-ICD Systems

Wed, 04/20/2016 - 13:30
European Approval Granted for Third-Generation System and All Previously Implanted, Second-Generation Systems MARLBOROUGH, Mass., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) has received CE Mark approval for the ...
Devices, Cardiology, Regulatory
Boston Scientific, EMBLEM MRI, Subcutaneous Implantable Defibrillator, ICD

Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn(TM) for Use Following Laser Procedures, Microdermabrasions and Chemical Peels

Wed, 04/20/2016 - 13:23
PETALUMA, Calif., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological condit...
Biopharmaceuticals, Dermatology, FDA
Oculus Innovative Sciences, Microcyn, Lasercyn Gel

Alma Surgical to Launch the 2nd Generation Femilift, the Femilift Smart, a New Robotic Probe for Advanced Precision and Faster Treatment of Feminine Health Concerns

Wed, 04/20/2016 - 13:17
The FemiLift Smart, a New Robotic Probe for Homogeneous & Faster Treatments ROME, April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Alma Surgical, a division of Alma Lasers, a global innovator of laser, light-based, radiofrequency and ultraso...
Devices, Product Launch
Alma Surgical, Alma Lasers, FemiLift Smart

Enterome Raises EUR14.5 Million in Series C Financing Round

Wed, 04/20/2016 - 13:09
Nestlé Health Science Invests Alongside Existing Investors PARIS and BOSTON, April 20, 2016 -- (Healthcare Sales & Marketing Network) -- ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut mic...
Biopharmaceuticals, Gastroenterology, Venture Capital
Enterome Bioscience, gut microbiome, inflammatory bowel disease

John Lapré to Fulfill Role as Elekta’s Chief Technology Officer

Wed, 04/20/2016 - 13:02
STOCKHOLM--(Healthcare Sales & Marketing Network)--In order to further strengthen its innovation leadership, Elekta (EKTA-B.ST) announced today the appointment of John Lapré as Chief Technology Officer, effective May 1, 2016. John Lapré sa...
Devices, Oncology, Neurosurgery, Personnel
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Caltorque Medical Products Expands Portfolio of Cost Responsible(SM) Surgical Instruments

Tue, 04/19/2016 - 17:30
Orthopedic Medical Device OEM's access the most Robust, Diverse Featured and reliable Single Procedure, Multiple Procedure and instrument portfolio at significant cost responsible(sm) pricing Chino, CA -- (Healthcare Sales & Marketing Network) -- Caltor...
Devices, Surgery, Product Launch
Caltorque Medical Products

Rodney D. Altman, MD Joins Valeritas Board of Directors

Tue, 04/19/2016 - 15:59
Valeritas Expands Its Board of Directors BRIDGEWATER, New Jersey, April 19, 2016 -- (Healthcare Sales & Marketing Network) -- Valeritas, Inc. announced today that Rodney D. Altman, MD has been elected to the company's board as an independent director. ...
Devices, Drug Delivery, Endocrinology, Personnel
Valeritas, V-Go, Insulin Delivery

St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark

Tue, 04/19/2016 - 15:54
Prominent European electrophysiology labs and hospitals have embraced the next generation mapping system’s automation, flexibility and precision for tailoring treatment for patients with cardiac arrhythmias ST. PAUL, MN--(Healthcare Sales & Marketing Ne...
Devices, Cardiology, Product Launch
St. Jude Medical, EnSite Precision, electrophysiology

Advanced Catheter Therapies Signs Worldwide License Agreement With Toray Industries, Inc. for the Occlusion Perfusion Catheter(R)

Tue, 04/19/2016 - 15:50
CHATTANOOGA, TN--(Healthcare Sales & Marketing Network) - Advanced Catheter Therapies, Inc. (ACT) announced today that it has signed a worldwide License Agreement with Toray Industries, Inc. (TORAY) to manufacture, market and sell the patented and FDA-cle...
Devices, Interventional, Licensing, Distribution
Advanced Catheter Therapies, Toray Industries, Occlusion Perfusion Catheter

DalCor Pharmaceuticals Completes $150 Million Financing

Tue, 04/19/2016 - 15:28
Proceeds to Fund Phase 3 Trial of Dalcetrapib in Genetically Distinct Patients with Acute Coronary Syndrome (ACS) LONDON, April 19, 2016 -- (Healthcare Sales & Marketing Network) -- DalCor Pharmaceuticals today announced the completion of $150 million...
Biopharmaceuticals, Cardiology, Venture Capital, Personnel
DalCor Pharmaceuticals

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong